Clarification on the assessment of ATMPs
Boyds has welcomed the very timely final Regulation (EU) 2018/781 from the European Commission which describes the criteria to be used in the assessment of similarity for orphan designated ATMPs. Previous to this, the only definitions and examples available were suited to NCEs and biologics. This is timely because increasingly, owing to a significant rise […]
